NUProtein Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

NUProtein General Information

Description

Developer of a protein synthesis technology designed to address the problem of protein deficiency in humans. The company's technology synthesizes proteins artificially using technology and produces a protein in a short amount of time, enabling patients to get an affordable artificial protein as an alternative to natural protein.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3-20 Showa-cho
  • Tokushima, 770-0942
  • Japan
+81
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 3-20 Showa-cho
  • Tokushima, 770-0942
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NUProtein Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 01-Dec-2025 Completed Generating Revenue
7. Accelerator/Incubator 06-Mar-2023 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
5. Equity Crowdfunding 28-Dec-2022 Cancelled Generating Revenue
4. Equity Crowdfunding 18-Oct-2021 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
2. Seed Round 13-Sep-2017 $1.1K $1.1K Completed Generating Revenue
1. Grant 13-Mar-2017 $167K Completed Generating Revenue
To view NUProtein’s complete valuation and funding history, request access »

NUProtein Patents

NUProtein Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024174394-A Method for producing protein, method for producing cultured meat, additive used in method for producing cultured meat, and kit used in method for producing protein Active 05-Jun-2023
JP-2024174795-A Method for producing protein, method for producing cultured meat, additive used in method for producing cultured meat, and kit used in method for producing protein Pending 05-Jun-2023
WO-2024252714-A1 Method for producing protein, method for producing cultured meat, additive used in method for producing cultured meat, and kit used in method for producing protein Inactive 05-Jun-2023
US-20260258469-A1 Protein production method, cultured meat production method, additive used for cultured meat production method, and kit used for protein production method Pending 05-Jun-2023
JP-7426764-B1 Protein production methods, cultured meat production methods, additives used in cultured meat production methods, and kits used in protein production methods Active 05-Jun-2023 C12P21/02
To view NUProtein’s complete patent history, request access »

NUProtein Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NUProtein Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Life-Tech KOBE Accelerator/Incubator
Japan External Trade Organization Accelerator/Incubator
Intellectual Property Acceleration Program for Startups Accelerator/Incubator
International CSRC Investment Holdings Corporation Minority
Japan Finance Government Minority
To view NUProtein’s complete investors history, request access »

NUProtein FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process